MedTrace Logo

Transitioning Youth Out of Homelessness 2.5 (TYOH 2.5)

NCT06425458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-09-15

Study results available
· View outcomes & findings →

Summary

The idea for this study came from the research team's current study called Transitioning Youth Out of Homelessness (TYOH) 2.0, which provides coaching and a leadership guide to youth transitioning out of homelessness. Based on feedback from youth and coaches involved in that study, the research team plans to make small changes to the leadership guide and see if it works better as an in-person, four-week leadership program.

All participants in this study will be invited to attend an in-person, four-week leadership program. There will be two programs running at the same time: one in St. Catharines and one in Toronto. The goal is to have 15 participants in each program.

The main purpose of the study is to learn what participants think of the program. The second purpose is to see if there are changes in identity capital (feeling a sense of purpose and confidence in achieving goals) and knowledge about things that are covered in the program, when the research team compares participants' answers at the beginning and at the end of the program.

Conditions

  • Homelessness
  • Youth

Interventions

BEHAVIORAL

Co-Designed Strengths-Based Leadership Program

Please see arm description.

Sponsors & Collaborators

  • Covenant House Toronto

    collaborator OTHER

  • StepStones for Youth

    collaborator UNKNOWN

  • Resource Association for Teens

    collaborator OTHER

  • Unity Health Toronto

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-11
Primary Completion
2024-08-09
Completion
2024-08-09

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06425458 on ClinicalTrials.gov